BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21663414)

  • 1. Notch receptor and effector expression in von Hippel-Lindau disease-associated central nervous system hemangioblastomas.
    Merrill MJ; Edwards NA; Lonser RR
    J Neurosurg; 2011 Sep; 115(3):512-7. PubMed ID: 21663414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M; Marti HH; Plate KH
    Blood; 1998 Nov; 92(9):3388-93. PubMed ID: 9787178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinicopathologic study of von Hippel-Lindau syndrome-related and sporadic hemangioblastomas of central nervous system].
    Zhou J; Li NY; Zhou XJ; Zhou HB; Wu B; Jiang SJ; Ma HH; Zhang RS
    Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):145-50. PubMed ID: 20450758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of the von Hippel-Lindau Gene in Hemangioblasts Causes Hemangioblastoma-like Lesions in Murine Retina.
    Wang H; Shepard MJ; Zhang C; Dong L; Walker D; Guedez L; Park S; Wang Y; Chen S; Pang Y; Zhang Q; Gao C; Wong WT; Wiley H; Pacak K; Chew EY; Zhuang Z; Chan CC
    Cancer Res; 2018 Mar; 78(5):1266-1274. PubMed ID: 29301791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative genomic analyses on HES/HEY family: Notch-independent HES1, HES3 transcription in undifferentiated ES cells, and Notch-dependent HES1, HES5, HEY1, HEY2, HEYL transcription in fetal tissues, adult tissues, or cancer.
    Katoh M; Katoh M
    Int J Oncol; 2007 Aug; 31(2):461-6. PubMed ID: 17611704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma.
    Zhou J; Wang J; Li N; Zhang X; Zhou H; Zhang R; Ma H; Zhou X
    Pathol Int; 2010 Jun; 60(6):452-8. PubMed ID: 20518900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of stem cells markers in ocular hemangioblastoma associated with von Hippel-Lindau (VHL) disease.
    Chan CC; Chew EY; Shen D; Hackett J; Zhuang Z
    Mol Vis; 2005 Sep; 11():697-704. PubMed ID: 16163267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
    Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathology and CXCR4 expression in surgically excised retinal hemangioblastomas associated with von Hippel-Lindau disease.
    Liang X; Shen D; Huang Y; Yin C; Bojanowski CM; Zhuang Z; Chan CC
    Ophthalmology; 2007 Jan; 114(1):147-56. PubMed ID: 17070589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. von Hippel-Lindau disease-associated hemangioblastomas are derived from embryologic multipotent cells.
    Park DM; Zhuang Z; Chen L; Szerlip N; Maric I; Li J; Sohn T; Kim SH; Lubensky IA; Vortmeyer AO; Rodgers GP; Oldfield EH; Lonser RR
    PLoS Med; 2007 Feb; 4(2):e60. PubMed ID: 17298169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological study of vascular endothelial growth factor (VEGF), p53, and proliferative potential in familial von Hippel-Lindau disease and sporadic hemangioblastomas.
    Miyagami M; Katayama Y; Nakamura S
    Brain Tumor Pathol; 2000; 17(3):111-20. PubMed ID: 11310918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Von hippel-lindau disease: a genetic and clinical review.
    Haddad NM; Cavallerano JD; Silva PS
    Semin Ophthalmol; 2013; 28(5-6):377-86. PubMed ID: 24138046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal cells of hemangioblastomas exhibit mesenchymal stem cell-derived vascular progenitor cell properties.
    Takada S; Hojo M; Takebe N; Tanigaki K; Miyamoto S
    Brain Tumor Pathol; 2018 Oct; 35(4):193-201. PubMed ID: 29936560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Putative control of angiogenesis in hemangioblastomas by the von Hippel-Lindau tumor suppressor gene.
    Stratmann R; Krieg M; Haas R; Plate KH
    J Neuropathol Exp Neurol; 1997 Nov; 56(11):1242-52. PubMed ID: 9370235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Von Hippel-Lindau mutations disrupt vascular patterning and maturation via Notch.
    Arreola A; Payne LB; Julian MH; de Cubas AA; Daniels AB; Taylor S; Zhao H; Darden J; Bautch VL; Rathmell WK; Chappell JC
    JCI Insight; 2018 Feb; 3(4):. PubMed ID: 29467323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmentally arrested structures preceding cerebellar tumors in von Hippel-Lindau disease.
    Shively SB; Falke EA; Li J; Tran MG; Thompson ER; Maxwell PH; Roessler E; Oldfield EH; Lonser RR; Vortmeyer AO
    Mod Pathol; 2011 Aug; 24(8):1023-30. PubMed ID: 21499240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The β2-adrenergic receptor antagonist ICI-118,551 blocks the constitutively activated HIF signalling in hemangioblastomas from von Hippel-Lindau disease.
    Cuesta AM; Albiñana V; Gallardo-Vara E; Recio-Poveda L; de Rojas-P I; de Las Heras KVG; Aguirre DT; Botella LM
    Sci Rep; 2019 Jul; 9(1):10062. PubMed ID: 31296894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmentally Arrested Basket/Stellate Cells in Postnatal Human Brain as Potential Tumor Cells of Origin for Cerebellar Hemangioblastoma in von Hippel-Lindau Patients.
    Shively SB; Edwards NA; MacDonald TJ; Johnson KR; Diaz-Rodriguez NM; Merrill MJ; Vortmeyer AO
    J Neuropathol Exp Neurol; 2022 Oct; 81(11):885-899. PubMed ID: 35980299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease.
    Vortmeyer AO; Gnarra JR; Emmert-Buck MR; Katz D; Linehan WM; Oldfield EH; Zhuang Z
    Hum Pathol; 1997 May; 28(5):540-3. PubMed ID: 9158701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor.
    Zagzag D; Krishnamachary B; Yee H; Okuyama H; Chiriboga L; Ali MA; Melamed J; Semenza GL
    Cancer Res; 2005 Jul; 65(14):6178-88. PubMed ID: 16024619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.